Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001416268 | SCV001618447 | likely benign | Retinoblastoma | 2023-02-26 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002259118 | SCV002530836 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-06 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV001416268 | SCV004831084 | likely benign | Retinoblastoma | 2023-09-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002259118 | SCV005160592 | likely benign | Hereditary cancer-predisposing syndrome | 2024-06-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |